Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Aldeyra Therapeutics (137.F) Q2 2024 Earnings
137.F
2
May
Confirmed
Q4 2023
Q2 2024
-0.13
-0.11
-0.09
-0.07
Details
Expected EPS
-0.1031135625
Actual EPS
-0.13049400000000003
Surprise EPS
-0.03
Surprise Percent
+26.55%
Description
Aldeyra Therapeutics (137.F) has reported earnings of -0.13049400000000003 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login